Literature DB >> 2385658

Surgical correction of exophthalmos secondary to Graves' disease.

S R Thaller1, H K Kawamoto.   

Abstract

Graves' disease has been recorded in the medical literature for more than 150 years. Despite introduction of iodine into the diet, Graves' disease still remains the most important disorder of the thyroid gland. Clinically, Graves' disease is a multisystem disorder of unknown etiology characterized by the clinical triad of infiltrative pretibial dermopathy, thyroid glandular hyperplasia, and ophthalmopathy. Expansion of the bony orbital volume is an effective method of treating moderate to severe exophthalmos. Our experience with a simplified version of a three-wall orbital decompression to correct exophthalmos secondary to Graves' disease is presented.

Entities:  

Mesh:

Year:  1990        PMID: 2385658

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  4 in total

1.  Coronal approach for rehabilitative orbital decompression in Graves' ophthalmopathy.

Authors:  R Kalmann; M P Mourits; J P van der Pol; L Koornneef
Journal:  Br J Ophthalmol       Date:  1997-01       Impact factor: 4.638

2.  Graves' exophthalmos: Volumetric assessment of orbital expansion.

Authors:  Ramon S Grover; James Mainprize; Edsel Ing; Oleh M Antonyshyn
Journal:  Can J Plast Surg       Date:  2003

Review 3.  Critical Appraisal on Orbital Decompression for Thyroid Eye Disease: A Systematic Review and Literature Search.

Authors:  Konstadinos G Boboridis; Jimmy Uddin; Dimitrios G Mikropoulos; Catey Bunce; George Mangouritsas; Irini C Voudouragkaki; Anastasios G P Konstas
Journal:  Adv Ther       Date:  2015-07-23       Impact factor: 3.845

4.  Reduction of orbital inflammation following decompression for thyroid-related orbitopathy.

Authors:  Sang-Rog Oh; Jonathan D Tung; Ayelet Priel; Leah Levi; David B Granet; Bobby S Korn; Don O Kikkawa
Journal:  Biomed Res Int       Date:  2013-06-18       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.